Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-073586

Chief Financial Officer acquired 15,441 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Robins Jason Shand · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-10 Grant or award : show line 1 in the form +15,441 68,097 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-10 Grant or award : show line 2 in the form Stock Option (Right to Buy) +14,024 14,024 D
Loading xslF345X06/tm2617745-5_4seq1.xml…